PhD Scientific Days 2025

Poster Session I. - F: Pharmaceutical Sciences and Health Technologies

Study on the pharmacists' contribution in elderly/aged patients' therapeutic adherence to statin therapy: a randomized controlled trial

Előadó neve

Dr. Artner Anna

Neptun code

B8XAAW

Előadó munkahelye

Semmelweis University, University Pharmacy - Department of Pharmacy Administration

Előadó telefonszáma

+36304764752

Előadó e-mail címe

artner.anna@semmelweis.hu

Az előadás címe

Study on the pharmacists' contribution in elderly/aged patients' therapeutic adherence to statin therapy: a randomized controlled trial

Szerző(k) neve és munkahelye

Artner Anna¹, Hankó Balázs¹, Eőry Ajándék², Torzsa Péter², Zelkó Romána¹

1: Semmelweis Egyetem, Egyetemi Gyógyszertár – Gyógyszerügyi Szervezési Intézet
2: Semmelweis Egyetem, Családorvosi Tanszék

Bemutatás módja

Poszter

Szekció

Poster Session I. - F: Pharmaceutical Sciences and Health Technologies

Language of the presentation

English

Preferred session

Pharmaceutical Sciences and Health Technologies

Összefoglaló szövege

Abstract
Introduction: Cardiovascular diseases are among the leading causes of death worldwide, particularly among elderly, polymorbid patients who often take multiple medications (polypharmacy). Statin therapy effectively reduces cardiovascular risk, but adherence is often low, which negatively impacts treatment outcomes. The involvement of pharmacists in patient care offers an opportunity to reduce medication-related problems, improve adherence, and support doctor-patient communication.
Aims: This study aims to examine, through a randomized controlled trial, how pharmaceutical care and pharmacist-led interventions in general practice can optimize medication therapy in polymorbid patients over 65 years of age receiving statin treatment.
Methods: In this 12-month follow-up study, 100 patients are randomly assigned to intervention and control groups. The intervention group receives pharmacist consultations, including structured counseling, medication review, and patient education, while the control group continues to receive usual care from their general practitioner. Data collection takes place in collaboration with the GP, both in person and through the Electronic Health Service Space (EESZT) system. Ethics approval number: SE RKEB: 192/2024.
Results: The findings highlight the impact of personalized pharmaceutical care in general practice on optimizing medication use, improving adherence, and enhancing cardiovascular outcomes. The collaboration between general practitioners and pharmacists may improve the quality of patient care, while active patient involvement and increased health literacy could lead to sustainable health improvements.
Conclusion: Pharmaceutical care in general practice is a potentially effective tool for optimizing medication therapy in elderly patients—especially regarding statin therapy—thus contributing to cardiovascular risk reduction and overall improvement in patient care.
Keywords: statin therapy, adherence, pharmaceutical care, pharmacist-led interventions, general practice, elderly patients

University

Semmelweis University

Supervisor

Dr. Hankó Balázs, Dr. Zelkó Romána

Publication of my abstract

I give consent to the publication of my abstract on the website of the congress.

phd.section.field

in doctoral studies before complex exam (PhD)

Kind

Szabad

Status

elfogadva

Accepted presentation method

poszter

Előadás fájl jóváhagyás

nem rendelkezett róla

Előadó

8105

Start

16:54

End

17:00